Fig. 6: Comparing rates of myocarditis or of myocarditis/pericarditis by dose of BNT162b2 vaccination against COVID-19 among adolescents. | npj Vaccines

Fig. 6: Comparing rates of myocarditis or of myocarditis/pericarditis by dose of BNT162b2 vaccination against COVID-19 among adolescents.

From: Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination

Fig. 6

In panel a, Experimental refers to second dose and control to first dose; in panel b, experimental refers to second dose and control to any dose, in panel c, experimental refers to any dose and control to first dose; in panel d experimental refers to booster dose and control to second dose. Conditions are presented to consider sex. The whisker represents the 95% confidence interval. The inclusion period of participants spanned from December 2020 to February 2022.

Back to article page